Logan Capital Management’s Sanofi SNY Stock Holding History

Logan Capital Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.88M	Buy	+163,620	New	+$7.63M	0.34%	86

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Logan Capital Management's SNY Position: Q1 2026 in Review

Logan Capital Management sold out of Sanofi (SNY) in Q1 2026, closing a stake of 147,363 shares — an estimated $6.87M sold.

Logan Capital Management first reported a position in SNY in Q2 2013 and held it in 51 quarters. The position peaked at $7.14M in Q4 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

Logan Capital Management reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
Logan Capital Management sold 147,363 Sanofi shares in Q1 2026, an estimated $6.87M.
Logan Capital Management first reported a position in Sanofi in Q2 2013 and held it in 51 quarters.
Logan Capital Management's Sanofi position peaked at $7.14M in Q4 2025.
737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Logan Capital Management's 13F filing for Q1 2026, filed 8 May 2026.